Aclaris Therapeutics, Inc. (ACRS) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

Pattern note: compression remains elevated around 22%, which means breakout quality matters more than noise inside the pattern.

📊 Technical Summary

Aclaris Therapeutics, Inc. (ACRS) closed at 4.34 (-2.91%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is positive at +4.83%; price is trading in the upper part of its roughly 52-week range (1.18–4.55); and ATR14 volatility is elevated at roughly 5.43% of price. RSI(14) stands around 57.2, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. On the downside, 3.84 is the first support area. Holding above it helps keep the current structure more stable. Latest fundamentals snapshot: Revenue: 3.30M · Net income: -64.92M · EPS (basic): -0.12. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more